MFS
RETA

Mirabella Financial Services’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Mirabella Financial Services’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,403
Closed -$281K – 633
2022
Q4 		$281K Buy
+7,403
New +$255K 0.03% 264

Other funds holding RETA

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirabella Financial Services's RETA Position: Q1 2023 in Review

Mirabella Financial Services sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2023, closing a stake of 7,403 shares — an estimated $281K sold.

Mirabella Financial Services first reported a position in RETA in Q4 2022 and held it in 1 quarter. The position peaked at $281K in Q4 2022. 205 funds tracked by Wall St. Rank hold RETA as of Q1 2023.

  • Mirabella Financial Services reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 7,403 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2023, an estimated $281K.
  • Mirabella Financial Services first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • Mirabella Financial Services's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $281K in Q4 2022.
  • 205 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2023.

Based on Mirabella Financial Services's 13F filing for Q1 2023, filed 12 May 2023.